KHATTAR JACK A. (President, CEO) sold 0.2% of their position (1.90K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $91.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/3/2025ACC: 0001539937-25-000028
DirectorOfficer· President, CEO
Since Feb 2026
-1.90K
Net shares
Net seller
$91.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.27K acquired · 4.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.27K
Price / share
$25.30
Trade value
$57.36K
% of position
0.2%
10/2/2025
1.16M→1.16M
Common Stock
Direct
Shares
−1.90K
Price / share
$48.06
Trade value
$91.51K
% of position
0.2%
10/2/2025
1.16M→1.16M
Total
Net shares
+363.00
Net value
-$34.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2025 | M · Option Exercise | +2.27K | $25.30 | $57.36K | 0.2% | 1.16M | 1.16M |
| Common Stock Direct | 10/2/2025 | S · Sale | −1.90K | $48.06 | $91.51K | 0.2% | 1.16M | 1.16M |
| Total | +363.00 | -$34.15K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.27K shares
Shares
−2.27K
Strike price
25.30
Held after
81.25K
Exercisable
—
10/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock2.27K shares | 10/2/2025 | M · Option Exercise | −2.27K | 25.30 | — | 81.25K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.01M
Total
1.01M indirect1.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Total | 1.01M | 1.01M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported